"Vaccines, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
| Descriptor ID |
D014614
|
| MeSH Number(s) |
D12.776.828.868 D20.215.894.865 D23.050.865
|
| Concept/Terms |
Vaccines, Synthetic- Vaccines, Synthetic
- Synthetic Vaccines
- Synthetic Immunogens
- Immunogens, Synthetic
Molecular Vaccines- Molecular Vaccines
- Vaccines, Molecular
- Vaccines, Chemical
- Chemical Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Synthetic".
This graph shows the total number of publications written about "Vaccines, Synthetic" by people in this website by year, and whether "Vaccines, Synthetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 4 | 5 |
| 1995 | 4 | 2 | 6 |
| 1996 | 11 | 3 | 14 |
| 1997 | 4 | 5 | 9 |
| 1998 | 5 | 2 | 7 |
| 1999 | 5 | 1 | 6 |
| 2000 | 3 | 4 | 7 |
| 2001 | 1 | 5 | 6 |
| 2002 | 2 | 4 | 6 |
| 2003 | 4 | 2 | 6 |
| 2004 | 2 | 6 | 8 |
| 2005 | 2 | 4 | 6 |
| 2006 | 2 | 4 | 6 |
| 2007 | 3 | 4 | 7 |
| 2008 | 1 | 4 | 5 |
| 2009 | 0 | 5 | 5 |
| 2010 | 2 | 3 | 5 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 7 | 8 |
| 2013 | 0 | 2 | 2 |
| 2014 | 2 | 5 | 7 |
| 2015 | 1 | 5 | 6 |
| 2016 | 0 | 9 | 9 |
| 2017 | 2 | 7 | 9 |
| 2018 | 2 | 3 | 5 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 6 | 7 |
| 2021 | 4 | 14 | 18 |
| 2022 | 1 | 20 | 21 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines, Synthetic" by people in Profiles.
-
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster. Int J Infect Dis. 2024 Dec; 149:107271.
-
A Journey in Science: Molecular vaccines for global child health in troubled times of anti-science. Mol Med. 2024 Mar 15; 30(1):37.
-
Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 02; 19(2):e1011082.
-
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial. Clin Infect Dis. 2023 02 08; 76(3):e1168-e1176.
-
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters. N Engl J Med. 2023 02 09; 388(6):565-567.
-
Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States. Vaccine. 2022 11 28; 40(50):7187-7190.
-
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. J Infect Dis. 2022 09 13; 226(5):797-807.
-
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. JAMA Netw Open. 2022 09 01; 5(9):e2233273.
-
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection. Clin Infect Dis. 2022 08 24; 75(1):e827-e837.
-
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans. BMJ Open. 2022 08 03; 12(8):e063935.